Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 14 Prostatic Neoplasms 4 Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Precancerous Conditions 2 Peripheral Nervous System Diseases 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Cardiovascular Diseases 2 Breast Carcinoma In Situ 2 Weight Loss 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Psoriasis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyps 1 Polycystic Ovary Syndrome 1 Pain 1 Ovarian Neoplasms 1 Osteoarthritis 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Cisplatin 109 Radiotherapy 100 Fluorouracil 90 Paclitaxel 75 Oxaliplatin 63 Docetaxel 56 Carboplatin 55 Irinotecan 41 Esophagectomy 41 Leucovorin 40 Capecitabine 39 Radiation 36 Surgical Procedures, Operative 35 Drug Therapy 31 Neoadjuvant Therapy 25 Chemoradiotherapy 18 Cetuximab 18 S 1 (combination) 17 pembrolizumab 16 camrelizumab 16 Nivolumab 15 Magnetic Resonance Spectroscopy 15 Bevacizumab 15 Blood Specimen Collection 14 Surveys and Questionnaires 12 Radiotherapy, Intensity-Modulated 12 Immunotherapy 11 Epirubicin 11 Biopsy 11 Trastuzumab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Esophageal Neoplasms × Fatty Acids, Omega-3 × Clear all

NCT07272382 2025-12-09

ESO-Shanghai28

Fudan University

Phase NA Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡